Decline of FEV1 by age and smoking status: Facts, figures, and fallacies

Thorax

Volumn 52, Issue 9, 1997, Pages 820-827

  Kerstjens, Huib A M ^a   Rijcken, Bert ^a   Scheuten, Jan P ^a   Postma, Dirkje S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE;

AGING; DETERIORATION; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; ADULT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; FEMALE; LUNG; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; VITAL CAPACITY;

ADULT; AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; REFERENCE VALUES; SMOKING; VITAL CAPACITY;

EID: 0030613527     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.9.820     Document Type: Review

References (83)

1. Tager IB, Segal MR, Speizer FE, Weiss ST. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis 1988;138:837-49.
2. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
3. Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971;103:57-67.
4. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
5. Brandli O, Schindler G, Kunzli N, Keller R, Perruchoud AP, Sapaldia team. Lung function in healthy never smoking adults:reference values and lower limits of normal of a Swiss population. Thorax 1996;51:277-83.
6. van Pelt W, Borsboom GJJM, Rijcken B, Schouten JP, van Zomeren BC, Quanjer PH. Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. Am J Respir Crit Care Med 1994;149:1218-26.
7. Burrows B, Lebowitz MD, Camilli AE, Knudson RJ. Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis 1986;133:974-80.
8. Sherrill DL, Lebowitz MD, Knudson RJ, Burrows B. Smoking and symptom effects on the curves of lung function growth and decline. Am Rev Respir Dis 1991;144:17-22.
9. Quanjer PH. Standardized lung function testing. Bull Eur Physiopathol Respir 1983;19(Suppl 5):1-95.
10. Dockery DW, Ware JH, Ferris BG Jr, Glicksberg DS, Fay ME, Spiro A III, et al. Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am Rev Respir Dis 1985;131:511-20.
11. Ware JH, Dockery DW, Louis TA, Xu XP, Ferris BG Jr, Speizer FE. Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. Am J Epidemiol 1990;132:685-700.
12. Glindmeyer HW, Lefante JJ, McColloster C, Jones RN, Weill H. Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65. Am J Respir Cm Care Med 1995;151:412-22.
13. Weiss ST, Ware JH. Overview of issues in the longitudinal analysis of respiratory data. Am J Respir Crit Care Med 1996;154:S208-11.
14. Glindmeyer HW, Diem JH, Jones RN, Weill H. Non-comparibility of longitudinal and cross-sectionally determined annual chance in spirometry. Am Rev Respir Dis 1982;125:544-8.
15. Xu X, Laird N, Dockery, DW, Schouten JP, Rijcken B, Weiss ST. Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study. Am j Epidemiol 1995;141:554-66.
16. Kauffmann F, Tessier JF, Oriol P. Adult passive smoking in the home environment:a risk factor for chronic airflow limitation. Am J Epidemiol 1983;117:269-80.
17. Xu X, Li B. Exposure-response relationship between passive-smoking and adult pulmonary function. Am J Respir Crit Care Med 1995;151:41-6.
18. Fletcher CM, Peto R, Tinker CM, Speizer FE. The natural history of chronic bronchitis and emphysema. An eight-year study of early chronic obstructive lung disease in working men in London. Oxford:Oxford University Press, 1976.
19. Schouten JP, Tager IB. Interpretation of longitudinal studies:an overview. Am J Respir Crit Care Med 1996;154:S278-284.
20. Becklake MR. Concepts of normality applied to the measurement of lung function. Am J Med 1986;80:1158-64.
21. Cary J, Huseby J, Culver R, Kosanke C Jr. Variability in interpretation of pulmonary function tests. Chest 1979;76:389-90.
22. Buist AS. Evaluation of lung function:concepts of normality. In:Simmons DH, ed. Current pulmonology. New York:John Wiley & Sons, 1982:141-65.
23. Miller MR, Pincock AC. Predicted values:how should we use them? Thorax 1988;43:265-7.
24. Sobol BJ. Assessment of ventilatory abnormality in the asymptomatic subject:an exercise in futility. Thorax 1966;21:445-9.
25. American Thoracic Society. Lung function testing:selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
26. Quanjer PH. Lung volumes and forced ventilatory flows:report of Working Party Standardization of lung function tests European Community for Steel and Coal. Eur Respir J 1993;6(Suppl 16):5-40.
27. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Cm Care Med 1995;152:1107-36.
28. Wypij D. Spline and smoothing approaches to fitting flexible models for the analysis of pulmonary function data. Am J Respir Cm Care Med 1996;154:S223-8.
29. Enright PL, Adams AB, Boyle PJ, Sherrill DL. Spirometry and maximal respiratory pressure references from healthy Minnesota 65- to 85-year-old women and men. Chest 1995;108:663-9.
30. Enright PL, Kronmal RA, Higgins M, Schenker M, Haponik EF. Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. Am Rev Respir Dis 1993;147:125-33.
31. Smith WDE, Cunningham DA, Patterson DH, Rechnitzer PA, Koval JJ. Forced expiratory volume, height, and demispan in Canadian men and women aged 55-86. J Gerontol 1992;47:M40-4.
32. Samet JM, Lange P. Longitudinal studies of active and passive smoking. Am J Respir Crit Care Med 1996;154:S257-65.
33. Young S, Le Souëf PN, Geelhoed GC, Stick SM, Turner KJ, Landau LI. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991;324:1168-73.
34. Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy:effects on lung function during the first 18 months of life. Am J Respir Crit Can Med 1995;152:977-83.
35. Tager IB, Weiss ST, Munoz A, Rosner B, Speizer FE. Longitudinal study of the effects of maternal smoking on pulmonary function in children. N Engl J Med 1983;309:699-703.
36. Wang X, Wypij D, Gold DR, Speizer FE, Ware JH, Ferris BG Jr, et al. A longitudinal study of the effects of parental smoking on pulmonary function in children 6-18 years. Am J Respir Crit Care Med 1994;149:1420-5.
37. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996;335:931-7.
38. Tager IB, Munoz A, Rosner B, Weiss S, Carey V. Effect of cigarette smoking on the pulmonary function of children and adolescents. Am Rev Respir Dis 1985;131:752-9.
39. Lebowitz MD, Holberg CJ, Knudson RJ, Burrows H. Longitudinal study of pulmonary function development in childhood, adolescence, and early adulthood. Development of pulmonary function. Am Rev Respir Dis 1987;136:69-75.
40. Fletcher CM, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.
41. 1 with time:indicators for effects of smoking and air pollution. Bull Eur Physiopathol Respir 1981;17:775-92.
42. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults. (Effects of smoking and smoking cessation). Am Rev Respir Dis 1987;135:794-9.
43. 1. Eur Respir J 1989;2:811-6.
44. 1 :new insight into gender differences. Eur Respir J 1994;7:1056-61.
45. US Department of Health and Human Services. A report of the Surgeon General:the health consequences of smoking chronic obstructive lung disease. Washington DC:US Government Printing Office, 1984.
46. Burchfiel CM, Marcus EB, Curb JD, MacLean CJ, Vollmer WM, Johnson LR, et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med 1995;151:1778-85.
47. Research Committee of the British Thoracic Society. Smoking cessation in patients:two further studies by the British Thoracic Society. Thorax 1990;45:835-40.
48. American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996;153:861-5.
49. Kerstjens HAM, Brand PLP, Postma DS. Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:S266-72.
50. Bosse R, Sparrow D, Rose CL, Weiss ST. Longitudinal effect of age and smoking cessation on pulmonary function. Am Rev Respir Dis 1981;123:378-81.
51. Tashkin DP, Clark VA, Coulson AH, Simmons M, Bourque LB, Reems C, et al. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function:a prospective study of a free-living population. Am Rev Respir Dis 1984;130:707-15.
52. 1:the Lung Health Study. JAMA 1994;272:1497-505.
53. Lange P, Groth S, Nyboe J, Mortensen J, Appleyard M, Jensen G, et al. Decline of the lung function related to the type of tobacco smoked and inhalation. Thorax 1990;45:22-6.
54. Dockery DW, Speizer FE, Ferris BG Jr, Ware JH, Louis TA, Spiro A III. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis 1988;137:286-92.
55. Viegi G, Paoletti P, Prediletto R, Carrozzi L, Fazzi P, Di Pede F, et al. Prevalence of respiratory symptoms in an unpolluted area of Northern Italy. Ear Respir J 1988;1:311-8.
56. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994;7:477-83.
57. Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis 1991;143:1224-30.
58. Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992;146:855-9.
59. Wang M, McCabe L, Hankinson JL, Shamssain MH, Gunel E, Lapp NL, et al. Longitudinal and cross-sectional analyses of lung function in steelworkers. Am J Respir Crit Care Med 1996;153:1907-13.
60. Chinn DJ, Cotes JE, Reed JW. Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 1996;51:699-704.
61. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-9.
62. Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317:1309-14.
63. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994;150:629-34.
64. Schachter EN, Doyle CA, Beck GJ. A prospective study of asthma in a rural community. Chest 1984;5:623-30.
65. Postma DS, Panhuysen CIM, Kerstjens HAM. Chronic complications of asthma. In:O'Byrne PM, Thomson NC, eds. Manual of asthma management. London:WB Saunders, 1995:739-64.
66. Campbell AH, Barter CE, O'Connell JM, Huggins R. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 1985;40:741-8.
67. Postma DS, de Vries K, Koëter GH, Sluiter HJ. Independent influence of reversibility of air-flow obstruction and non-specific hyperreactivity on the long-term course of lung function in chronic airflow obstruction. Am Rev Respir Dis 1986;134:276-80.
68. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA, et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:1802-11.
69. O'Connor GT, Sparrow D, Weiss ST. The role of allergy and non-specific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. State of the art. Am Rev Respir Dis 1989;140:225-52.
70. Rijcken B, Weiss ST. Longitudinal analyses of airway responsiveness and pulmonary function decline. Am J Respir Crit Care Med 1996;154:S246-9.
71. Britton J, Martinez FD. The relationship of childhood respiratory infection to growth and decline in lung function. Am J Respir Crit Care Med 1996;154:S240-5.
72. Dockery DW, Brunekreef B. Longitudinal studies of air pollution effects on lung function. Am J Respir Crit Care Med 1996;154:S250-6.
73. Hendrick DJ. Occupation and chronic obstructive pulmonary disease (review). Thorax 1996;51:947-55.
74. Christiani DC. Organic dust exposure and chronic airways disease (editorial). Am J Respir Crit Care Med 1996;154:833-4.
75. Poirier KP. A quantitative definition of obstructive lung disease (editorial). Am J Med 1968;45:329-35.
76. Dockery DW. Percentile curves for evaluation of repeated measures of lung function. Occup Med 1993;8:323-38.
77. Glindmeyer HW III. Predictable confusion. J Occup Med 1981;23:845-9.
78. Sobol BJ. Some cautions in the use of routine spirometry. Arch Intern Med 1966;118:335-9.
79. Miller A, Thornton JC, Smith H Jr, Morris JF. Spirometric "abnormality" in a normal male reference population:further analysis of the 1971 Oregon survey. Am J Ind Med 1980;1:55-68.
80. Lebowitz MD, Holberg CJ. Comparisons of spirometric reference values and the proportions of abnormal subjects among male smokers and those symptomatic in a community population. Am Rev Respir Dis 1990;141:1491-6.
81. Roberts CM, Macrae KD, Winning AJ, Adams L, Seed WA. Reference values and prediction equations for normal lung function in a non-smoking white urban population. Thorax 1991;46:643-50.
82. Kerstjens HAM, Brand PLP, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy in obstructive airways disease. N Engl J Med 1992;327:1413-9.
83. Parker JM, Dillard TA, Phillips YY. Impact of using stated instead of measured height upon screening spirometry. Am J Respir Crit Care Med 1994;150:1705-8.